Tharimmune, Inc. (THAR)
2.70
+0.10
(+3.85%)
USD |
NASDAQ |
Dec 10, 16:00
2.63
-0.07
(-2.59%)
After-Hours: 19:26
Tharimmune Shareholders Equity (Quarterly): 6.155M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 9.839M |
| ETHZilla Corp. | 445.14M |
| Flora Growth Corp. | 64.92M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.699M |
| Total Liabilities (Quarterly) | 1.545M |
| Debt to Equity Ratio | 0.0318 |
| Current Ratio | 4.985 |
| Net Debt Paydown Yield | 0.00% |